MME and neoplasm: Anti-GPR77 antibody injection can significantly reduce the infiltration of CD10+GPR77+CAFs (pro-tumor subsets of CAFs), and anti-GPR77 antibody combined with chemotherapy can significantly enhance the apoptosis of tumor cells and CAFs, and inhibit tumor growth [124].